Theradaptive, a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, is pleased to announce the appointment of Daniel Wolf as Chief Financial Officer ...

Enlivex Therapeutics (ENLV) announced that the Company completed enrollment of all patients in the Phase II stage of its randomized, ...

Alector has completed subject enrolment in the 76-week, randomised, Phase II PROGRESS-AD trial, which is assessing the efficacy and safety of AL101/GSK4527226, in individuals with early Alzheimer ...

Enlivex Therapeutics Ltd. has announced the completion of patient enrollment in the Phase II stage of its clinical trial for Allocetra™, an immunotherapy for moderate to severe knee ...

today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric cancer patients with MET amplification. This clinical trial is a single ...

Strong product sales and key progress in pipeline catalysts LUND, Sweden, April 24, 2025 /PRNewswire/ -- Hansa Biopharma AB, Ha ...

California introduced the first phase of its ambitious Cradle-to-Career data system Tuesday, making it one of the few states ...

Take your time vetting vendors, ask the tough questions, and never settle for support that will vanish after implementation.